Federated Hermes
KNSA icon

Federated Hermes’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Federated Hermes’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,292
Closed -$60K – 2255
2021
Q3 		$60K Buy
5,292
+4,939
+1,399% +$64.3K ﹤0.01% 1841
2021
Q2 		$5K Sell
353
-241
-41% -$3.66K ﹤0.01% 2033
2021
Q1 		$11K Hold
594
– – ﹤0.01% 1995
2020
Q4 		$10K Sell
594
-411,839
-100% -$7.23M ﹤0.01% 1985
2020
Q3 		$6.32M Buy
412,433
+16,313
+4% +$306K 0.01% 680
2020
Q2 		$10.1M Buy
396,120
+181,021
+84% +$3.78M 0.03% 539
2020
Q1 		$3.33M Buy
+215,099
New +$3.37M 0.01% 741

Other funds holding KNSA

PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Federated Hermes's KNSA Position: Q4 2021 in Review

Federated Hermes sold out of Kiniksa Pharmaceuticals (KNSA) in Q4 2021, closing a stake of 5,292 shares — an estimated $60K sold.

Federated Hermes first reported a position in KNSA in Q1 2020 and held it in 7 quarters. The position peaked at $10.1M in Q2 2020. 103 funds tracked by Wall St. Rank hold KNSA as of Q4 2021.

  • Federated Hermes reported no remaining Kiniksa Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Federated Hermes sold 5,292 Kiniksa Pharmaceuticals shares in Q4 2021, an estimated $60K.
  • Federated Hermes first reported a position in Kiniksa Pharmaceuticals in Q1 2020 and held it in 7 quarters.
  • Federated Hermes's Kiniksa Pharmaceuticals position peaked at $10.1M in Q2 2020.
  • 103 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q4 2021.

Based on Federated Hermes's 13F filing for Q4 2021, filed 14 Feb 2022.